Exchange: OTC·Updated 11:24 AM EDT
About MBGNF
Many Bright Ideas Technologies, Inc. operates as a life science company. It engages in the development and commercialization of genomic-based clinical laboratory diagnostic tests. The company focuses on managing the license and rights for GeneFx Lung, a prognostic genomic-based test for non-small-cell lung cancer. The company was founded on April 28, 2006 and is headquartered in Vancouver, Canada.